Table of Content

Chapter 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Research methodology

1.3.1.Secondary research
1.3.2.Primary research
1.3.3.Analyst tools and models

Chapter 2:EXECUTIVE SUMMARY

2.1.CXO perspective

Chapter 3:MARKET OVERVIEW

3.1.Market definition and scope

3.1.1.Drivers

3.1.1.1.Diversification of services
3.1.1.2.Genetic testing, fertility, and reproduction assisted services
3.1.1.3.Treatment for chronic diseases
3.1.1.4.Rise in spending capacity and suitable payment plans

3.1.2.Restraints

3.1.2.1.Legal and ethical issues during collection
3.1.2.2.Higher cost of therapies
3.1.2.3.Unavailability of suitable matched donor

3.1.3.Opportunities

3.1.3.1.Advancements in therapeutic applications
3.1.3.2.Rise in funds for public storage

3.1.4.Value chain analysis of stem cell umbilical cord blood market

3.2.Top Player Positioning, 2019

Chapter 4:STEM CELL UMBILICAL CORD BLOOD MARKET, BY STORAGE SERIVCES

4.1.Overview

4.1.1.Market size and forecast

4.2.Public Cord Blood Banks

4.2.1.Overview
4.2.2.Key growth trends and opportunities
4.2.3.Market size and forecast
4.2.4.Market analysis, by country

4.3.Private Cord Blood Banks

4.3.1.Overview
4.3.2.Key growth trends and opportunities
4.3.3.Market size and forecast
4.3.4.Market analysis, by country

4.4.Hybrid Cord Blood Banks

4.4.1.Overview
4.4.2.Market size and forecast
4.4.3.Market analysis, by country

Chapter 5:STEM CELL UMBILICAL CORD BLOOD MARKET, BY THERAPEUTICS

5.1.Overview

5.1.1.Market size and forecast

5.2.Cancer

5.2.1.Overview
5.2.2.Market size and forecast
5.2.3.Market analysis, by country

5.3.Diabetes

5.3.1.Overview
5.3.2.Market size and forecast
5.3.3.Market analysis, by country

5.4.Blood diseases

5.4.1.Overview
5.4.2.Market size and forecast
5.4.3.Market analysis, by country

5.5.Immune Disorders

5.5.1.Overview
5.5.2.Market size and forecast
5.5.3.Market analysis, by country

5.6.Metabolic Disorders

5.6.1.Overview
5.6.2.Market size and forecast
5.6.3.Market analysis, by country

5.7.Others

5.7.1.Overview
5.7.2.Market size and forecast
5.7.3.Market analysis, by country

Chapter 6:STEM CELL UMBILICAL CORD BLOOD MARKET, BY APPLICATION

6.1.Overview

6.1.1.Market size and forecast

6.2.Transplant Medicine

6.2.1.Overview
6.2.2.Market size and forecast
6.2.3.Market analysis, by country

6.3.Regenerative Medicine

6.3.1.Overview
6.3.2.Market size and forecast
6.3.3.Market analysis, by country

Chapter 7:STEM CELL UMBILICAL CORD BLOOD MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends and opportunities
7.2.2.Market size and forecast, by country
7.2.3.Market size and forecast, by storage service
7.2.4.Market size and forecast, by therapeutics
7.2.5.Market size and forecast, by application
7.2.6.U.S.

7.2.6.1.U.S. market size and forecast, by storage service
7.2.6.2.U.S. market size and forecast, by therapeutics
7.2.6.3.U.S. market size and forecast, by application

7.2.7.Canada

7.2.7.1.Canada market size and forecast, by storage service
7.2.7.2.Canada market size and forecast, by therapeutics
7.2.7.3.Canada market size and forecast, by application

7.2.8.Mexico

7.2.8.1.Mexico market size and forecast, by storage service
7.2.8.2.Mexico market size and forecast, by therapeutics
7.2.8.3.Mexico market size and forecast, by application

7.3.Europe

7.3.1.Europe market size and forecast, by country
7.3.2.Europe market size and forecast, by storage service
7.3.3.Europe market size and forecast, by therapeutics
7.3.4.Europe market size and forecast, by application
7.3.5.UK

7.3.5.1.UK market size and forecast, by storage service
7.3.5.2.UK market size and forecast, by therapeutics
7.3.5.3.UK market size and forecast, by application

7.3.6.France

7.3.6.1.France market size and forecast, by storage service
7.3.6.2.France market size and forecast, by storage service
7.3.6.3.France market size and forecast, by therapeutics
7.3.6.4.France market size and forecast, by application

7.3.7.Germany

7.3.7.1.Germany market size and forecast, by storage service
7.3.7.2.Germany market size and forecast, by therapeutics
7.3.7.3.Germany market size and forecast, by application

7.3.8.Italy

7.3.8.1.Italy market size and forecast, by storage service
7.3.8.2.Italy market size and forecast, by therapeutics
7.3.8.3.Italy market size and forecast, by application

7.3.9.Spain

7.3.9.1.Spain market size and forecast, by storage service
7.3.9.2.Spain market size and forecast, by therapeutics
7.3.9.3.Spain market size and forecast, by application

7.3.10.Rest of Europe

7.3.10.1.Rest of Europe market size and forecast, by storage service
7.3.10.2.Rest of Europe market size and forecast, by therapeutics
7.3.10.3.Rest of Europe market size and forecast, by application

7.4.Asia-Pacific

7.4.1.Key market trends and opportunities
7.4.2.Asia-Pacific market size and forecast, by country
7.4.3.Asia-Pacific market size and forecast, by storage service
7.4.4.Asia-Pacific market size and forecast, by therapeutics
7.4.5.Asia-Pacific market size and forecast, by application
7.4.6.Japan

7.4.6.1.Japan market size and forecast, by storage service
7.4.6.2.Japan market size and forecast, by therapeutics
7.4.6.3.Japan market size and forecast, by application

7.4.7.China

7.4.7.1.China market size and forecast, by storage service
7.4.7.2.China market size and forecast, by therapeutics
7.4.7.3.China market size and forecast, by application

7.4.8.India

7.4.8.1.India market size and forecast, by storage service
7.4.8.2.India market size and forecast, by therapeutics
7.4.8.3.India market size and forecast, by application

7.4.9.Rest of Asia-Pacific

7.4.9.1.Rest of Asia-Pacific market size and forecast, by storage service
7.4.9.2.Rest of Asia-Pacific market size and forecast, by therapeutics
7.4.9.3.Rest of Asia-Pacific market size and forecast, by application

7.5.LAMEA

7.5.1.Key market trends and opportunities
7.5.2.LAMEA market size and forecast, by country
7.5.3.LAMEA market size and forecast, by storage service
7.5.4.LAMEA market size and forecast, by therapeutics
7.5.5.LAMEA market size and forecast, by application
7.5.6.Brazil

7.5.6.1.Brazil market size and forecast, by storage service
7.5.6.2.Brazil market size and forecast, by therapeutics
7.5.6.3.Brazil market size and forecast, by application

7.5.7.South Africa

7.5.7.1.South Africa market size and forecast, by storage service
7.5.7.2.South Africa market size and forecast, by therapeutics
7.5.7.3.South Africa market size and forecast, by application

7.5.8.Saudi Arabia

7.5.8.1.Saudi Arabia market size and forecast, by storage service
7.5.8.2.Saudi Arabia market size and forecast, by therapeutics
7.5.8.3.Saudi Arabia market size and forecast, by application

7.5.9.Rest of LAMEA

7.5.9.1.Rest of LAMEA market size and forecast, by storage service
7.5.9.2.Rest of LAMEA market size and forecast, by therapeutics
7.5.9.3.Rest of LAMEA market size and forecast, by application

Chapter 8:COMPANY PROFILES

8.1.Americord Registry LLC

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio

8.2.China Cord Blood Corporation

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Business performance

8.3.Cord Blood America, Inc.

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments

8.4.Cordlife Group Limited

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.4.6.Key strategic moves and developments

8.5.Cryo-Cell International, Inc.

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance

8.6.Esperite N.V.

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio

8.7.LifeCell International Pvt. Ltd.

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio

8.8.Medipost Co. Ltd.

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments

8.9.ViaCord

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio

8.10.Vita34 AG

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance



List of Figures



FIGURE 01.TOP PLAYER POSITIONING, 2019
FIGURE 02.COMPARATIVE SHARE ANALYSIS FOR PUBLIC CORD BLOOD BANKS MARKET BY COUNTRY, 2019 & 2027 (%)
FIGURE 03.COMPARATIVE SHARE ANALYSIS OF PRIVATE CORD BLOOD BANKS MARKET BY COUNTRY, 2019 & 2027 (%)
FIGURE 04.COMPARATIVE SHARE ANALYSIS OF HYBRID CORD BLOOD BANKS MARKET BY COUNTRY, 2019 & 2027 (%)
FIGURE 05.COMPARATIVE SHARE ANALYSIS OF CANCER MARKET BY COUNTRY, 2019 & 2027 (%)
FIGURE 06.COMPARATIVE SHARE ANALYSIS OF DIABETES MARKET BY COUNTRY, 2019 & 2027 (%)
FIGURE 07.COMPARATIVE SHARE ANALYSIS OF BLOOD DISEASES MARKET BY COUNTRY, 2019 & 2027 (%)
FIGURE 08.COMPARATIVE SHARE ANALYSIS OF IMMUNE DISORDERS MARKET BY COUNTRY, 2019 & 2027 (%)
FIGURE 09.COMPARATIVE SHARE ANALYSIS OF METABOLIC DISORDERS MARKET BY COUNTRY, 2019 & 2027 (%)
FIGURE 10.COMPARATIVE SHARE ANALYSIS OF OTHERS MARKET BY COUNTRY, 2019 & 2027 (%)
FIGURE 11.COMPARATIVE SHARE ANALYSIS OF TRANSPLANT MEDICINE MARKET BY COUNTRY, 2019 & 2027 (%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF REGENERATIVE MEDICINE MARKET BY COUNTRY, 2019 & 2027 (%)

CHINA CORD BLOOD CORPORATION: NET SALES, 2017–2019 ($MILLION)

CORDLIFE GROUP LIMITED: NET SALES, 2017–2018 ($MILLION)
CORDLIFE: REVENUE SHARE BY SEGMENT, 2018 (%)
CRYO-CELL INTERNATIONAL: NET SALES, 2016–2018 ($MILLION)
CRYO CELL INTERNATIONALS: REVENUE SHARE BY SEGMENTS, 2018 (%)
MEDIPOST CO. LTD: NET SALES, 2017–2018 ($MILLION)
VITA34 INTERNATIONAL: NET SALES, 2017–2018 ($MILLION)


List of Tables



TABLE 01.STEM CELL UMBILICIAL CORD BLOOD MARKET, BY STORAGE SERVICE, 2019–2027 ($MILLION)
TABLE 02.STEM CELL UMBILICIAL CORD BLOOD MARKET, BY PUBLIC CORD BLOOD STORAGE, 2019–2027 ($MILLION)
TABLE 03.STEM CELL UMBILICIAL CORD BLOOD MARKET, BY PRIVATE CORD BLOOD STORAGE, 2019–2027 ($MILLION)
TABLE 04.STEM CELL UMBILICIAL CORD BLOOD MARKET, BY HYBRID CORD BLOOD STORAGE, 2019–2027 ($MILLION)
TABLE 05.STEM CELL UMBILICIAL CORD BLOOD MARKET, BY THERAPEUTICS , 2019–2027 ($MILLION)
TABLE 06.STEM CELL UMBILICIAL CORD BLOOD MARKET FOR CANCER , 2019–2027 ($MILLION)
TABLE 07.STEM CELL UMBILICIAL CORD BLOOD MARKET FOR DIABETES 2019–2027 ($MILLION)
TABLE 08.STEM CELL UMBILICIAL CORD BLOOD MARKET, BY THERAPEUTICS, 2019–2027 ($MILLION)
TABLE 09.STEM CELL UMBILICIAL CORD BLOOD MARKET FOR IMMUNE DISORDERS, 2019–2027 ($MILLION)
TABLE 10.STEM CELL UMBILICIAL CORD BLOOD MARKET FOR METABOLIC DISORDERS, 2019–2027 ($MILLION)
TABLE 11.GLOBAL STEM CELL UMBILICIAL CORD BLOOD MARKET, BY TYPE OF IMMUNE DISORDERS, 2019–2027 ($MILLION)
TABLE 12.GLOBAL STEM CELL UMBILICIAL CORD BLOOD MARKET FOR OTHERS 2019–2027 ($MILLION)
TABLE 13.STEM CELL UMBILICIAL CORD BLOOD MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 14.STEM CELL UMBILICIAL CORD BLOOD MARKET, FOR TRANSPLANT MEDICINE , 2019–2027 ($MILLION)
TABLE 15.STEM CELL UMBILICIAL CORD BLOOD MARKET, FOR REGENERATIVE MEDICINE , 2019–2027 ($MILLION)
TABLE 16.STEM CELL UMBLICIAL CORD BLOOD MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 17.NORTH AMERICA STEM CELL UMBILICIAL CORD BLOOD MARKET, BY COUNTRY, 2019 –2026 ($MILLION)
TABLE 18.NORTH AMERICA STEM CELL UMBILICIAL CORD BLOOD MARKET, BY STORAGE SERVICE, 2019–2027 ($MILLION)
TABLE 19.NORTH AMERICA STEM CELL UMBILICIAL CORD BLOOD MARKET, BY THERAPEUTICS, 2019–2026 ($MILLION)
TABLE 20.NORTH AMERICA STEM CELL UMBILICIAL CORD BLOOD MARKET, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 21.U.S. STEM CELL UMBILICIAL CORD BLOOD MARKET, BY STORAGE SERVICE, 2019–2027 ($MILLION)
TABLE 22.U.S. STEM CELL UMBILICIAL CORD BLOOD MARKET, BY THERAPEUTICS, 2019–2026 ($MILLION)
TABLE 23.U.S. STEM CELL UMBILICIAL CORD BLOOD MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 24.CANADA STEM CELL UMBILICIAL CORD BLOOD MARKET, BY STORAGE SERVICE, 2019–2027 ($MILLION)
TABLE 25.CANADA STEM CELL UMBILICIAL CORD BLOOD MARKET, BY THERAPEUTICS, 2019–2027 ($MILLION)
TABLE 26.CANADA STEM CELL UMBILICIAL CORD BLOOD MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 27.MEXICO STEM CELL UMBILICIAL CORD BLOOD MARKET, BY STORAGE SERVICE, 2019–2027 ($MILLION)
TABLE 28.MEXICO STEM CELL UMBILICIAL CORD BLOOD MARKET, BY THERAPEUTICS, 2019–2027 ($MILLION)
TABLE 29.MEXICO STEM CELL UMBILICIAL CORD BLOOD MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 30.EUROPE STEM CELL UMBILICIAL CORD BLOOD MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 31.EUROPE STEM CELL UMBILICIAL CORD BLOOD MARKET, BY STORAGE SERVICE, 2019–2027 ($MILLION)
TABLE 32.EUROPE STEM CELL UMBILICIAL CORD BLOOD MARKET, BY THERAPEUTICS, 2019–2027 ($MILLION)
TABLE 33.EUROPE STEM CELL UMBILICIAL CORD BLOOD MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 34.UK STEM CELL UMBILICIAL CORD BLOOD MARKET, BY STORAGE SERVICE, 2019–2027 ($MILLION)
TABLE 35.UK STEM CELL UMBILICIAL CORD BLOOD MARKET, BY THERAPEUTICS, 2019–2020 ($MILLION)
TABLE 36.UK STEM CELL UMBILICIAL CORD BLOOD MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 37.FRANCE STEM CELL UMBILICIAL CORD BLOOD MARKET, BY STORAGE SERVICE, 2019–2027 ($MILLION)
TABLE 38.FRANCE STEM CELL UMBILICIAL CORD BLOOD MARKET, BY THERAPEUTICS, 2019–2027 ($MILLION)
TABLE 39.FRANCE STEM CELL UMBILICIAL CORD BLOOD MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 40.GERMANY STEM CELL UMBILICIAL CORD BLOOD MARKET, BY STORAGE SERVICE, 2019–2027 ($MILLION)
TABLE 41.GERMANY STEM CELL UMBILICIAL CORD BLOOD MARKET, BY THERAPEUTICS, 2019S–2027 ($MILLION)
TABLE 42.GERMANY STEM CELL UMBILICIAL CORD BLOOD MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 43.ITALY STEM CELL UMBILICIAL CORD BLOOD MARKET, BY STORAGE SERVICE, 2019–2027 ($MILLION)
TABLE 44.ITALY STEM CELL UMBILICIAL CORD BLOOD MARKET, BY THERAPEUTICS, 2019–2027 ($MILLION)
TABLE 45.ITALY STEM CELL UMBILICIAL CORD BLOOD MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 46.SPAIN STEM CELL UMBILICIAL CORD BLOOD MARKET, BY STORAGE SERVICE, 2019–2027 ($MILLION)
TABLE 47.SPAIN STEM CELL UMBILICIAL CORD BLOOD MARKET, BY THERAPEUTICS, 2019–2027 ($MILLION)
TABLE 48.SPAIN STEM CELL UMBILICIAL CORD BLOOD MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 49.REST OF EUROPE STEM CELL UMBILICIAL CORD BLOOD MARKET, BY STORAGE SERVICE, 2019–2027 ($MILLION)
TABLE 50.REST OF EUROPE STEM CELL UMBILICIAL CORD BLOOD MARKET, BY THERAPEUTICS, 2019–2027 ($MILLION)
TABLE 51.REST OF EUROPE STEM CELL UMBILICIAL CORD BLOOD MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 52.ASIA-PACIFIC STEM CELL UMBILICIAL CORD BLOOD MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 53.ASIA-PACIFIC STEM CELL UMBILICIAL CORD BLOOD MARKET, BY STORAGE SERVICE, 2019–2027 ($MILLION)
TABLE 54.ASIA-PACIFIC STEM CELL UMBILICIAL CORD BLOOD MARKET, BY THERAPEUTICS, 2019–2027 ($MILLION)
TABLE 55.ASIA-PACIFIC STEM CELL UMBILICIAL CORD BLOOD MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 56.JAPAN STEM CELL UMBILICIAL CORD BLOOD MARKET, BY STORAGE SERVICE, 2019–2027 ($MILLION)
TABLE 57.JAPAN STEM CELL UMBILICIAL CORD BLOOD MARKET, BY THERAPEUTICS, 2019–2027 ($MILLION)
TABLE 58.JAPAN STEM CELL UMBILICIAL CORD BLOOD MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 59.CHINA STEM CELL UMBILICIAL CORD BLOOD MARKET, BY STORAGE SERVICE, 2019–2027 ($MILLION)
TABLE 60.CHINA STEM CELL UMBILICIAL CORD BLOOD MARKET, BY THERAPEUTICS, 2019–2027 ($MILLION)
TABLE 61.CHINA STEM CELL UMBILICIAL CORD BLOOD MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 62.INDIA STEM CELL UMBILICIAL CORD BLOOD MARKET, BY STORAGE SERVICE, 2019–2027 ($MILLION)
TABLE 63.INDIA STEM CELL UMBILICIAL CORD BLOOD MARKET, BY THERAPEUTICS, 2019–2027 ($MILLION)
TABLE 64.INDIA STEM CELL UMBILICIAL CORD BLOOD MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 65.REST OF ASIA-PACIFIC STEM CELL UMBILICIAL CORD BLOOD MARKET, BY STORAGE SERVICE, 2019–2027 ($MILLION)
TABLE 66.REST OF ASIA-PACIFIC STEM CELL UMBILICIAL CORD BLOOD MARKET, BY THERAPEUTICS, 2019–2027 ($MILLION)
TABLE 67.REST OF ASIA-PACIFIC STEM CELL UMBILICIAL CORD BLOOD MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 68.LAMEA STEM CELL UMBILICIAL CORD BLOOD MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 69.LAMEA STEM CELL UMBILICIAL CORD BLOOD MARKET, BY STORAGE SERVICE, 2019–2027 ($MILLION)
TABLE 70.LAMEA STEM CELL UMBILICIAL CORD BLOOD MARKET, BY THERAPEUTICS, 2019–2027 ($MILLION)
TABLE 71.LAMEA STEM CELL UMBILICIAL CORD BLOOD MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 72.BRAZIL STEM CELL UMBILICIAL CORD BLOOD MARKET, BY STORAGE SERVICE, 2019–2027 ($MILLION)
TABLE 73.BRAZIL STEM CELL UMBILICIAL CORD BLOOD MARKET, BY THERAPEUTICS, 2019–2027 ($MILLION)
TABLE 74.BRAZIL STEM CELL UMBILICIAL CORD BLOOD MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 75.SOUTH AFRICA STEM CELL UMBILICIAL CORD BLOOD MARKET, BY STORAGE SERVICE, 2019–2027 ($MILLION)
TABLE 76.SOUTH AFRICA STEM CELL UMBILICIAL CORD BLOOD MARKET, BY THERAPEUTICS, 2019–2027 ($MILLION)
TABLE 77.SOUTH AFRICA STEM CELL UMBILICIAL CORD BLOOD MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 78.SAUDI ARABIA STEM CELL UMBILICIAL CORD BLOOD MARKET, BY STORAGE SERVICE, 2019–2027 ($MILLION)
TABLE 79.SAUDI ARABIA STEM CELL UMBILICIAL CORD BLOOD MARKET, BY THERAPEUTICS, 2019–2027 ($MILLION)
TABLE 80.SAUDI ARABIA STEM CELL UMBILICIAL CORD BLOOD MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 81.REST OF LAMEA STEM CELL UMBILICIAL CORD BLOOD MARKET, BY STORAGE SERVICE, 2019–2027 ($MILLION)
TABLE 82.REST OF LAMEA STEM CELL UMBILICIAL CORD BLOOD MARKET, BY THERAPEUTICS, 2019–2027 ($MILLION)
TABLE 83.REST OF LAMEA STEM CELL UMBILICIAL CORD BLOOD MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 84.AMERICORD REGISTRY LLC: COMPANY SNAPSHOT
TABLE 85.AMERICORD: OPERATING SEGMENTS
TABLE 86.CRYO-CELL INTERNATIONALS: PRODUCT PORTFOLIO
TABLE 87.CHINA CORD BLOOD CORPORATION: COMPANY SNAPSHOT
TABLE 88.CHINA CORD BLOOD CORPORATION: OPERATING SEGMENTS
TABLE 89.CORD BLOOD AMERICA: COMPANY SNAPSHOT
TABLE 90.CORD BLOOD AMERICA: OPERATING SEGMENTS
TABLE 91.CORDLIFE GROUP LIMITED: COMPANY SNAPSHOT
TABLE 92.CORDLIFE GROUP LIMITED: OPERATING SEGMENTS
TABLE 93.CORDLIFE: PRODUCT PORTFOLIO
TABLE 94.CORDLIFE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 95.CRYO-CELL INTERNATIONAL INC.: COMPANY SNAPSHOT
TABLE 96.CRYO-CELL INTERNATIONALS: OPERATING SEGMENTS
TABLE 97.CRYO-CELL INTERNATIONALS OFFERS FOLLOWING SERVICES:CRYO-CELL INTERNATIONALS: PRODUCT PORTFOLIO
TABLE 98.ESPERITE: COMPANY SNAPSHOT
TABLE 99.ESPERITE: OPERATING SEGMENTS
TABLE 100.ESPERITE : PRODUCT PORTFOLIO
TABLE 01.LIFECELL: COMPANY SNAPSHOT
TABLE 02.LIFECELL: OPERATING SEGMENTS
TABLE 03.LIFECELL: PRODUCT PORTFOLIO
TABLE 04.MEDIPOST CO. LTD: COMPANY SNAPSHOT
TABLE 05.MEDIPOST CO. LTD: OPERATING SEGMENTS
TABLE 06.MEDIPOST CO. LTD: PRODUCT PORTFOLIO
TABLE 07.MEDIPOST CO. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 01.VIACORD : COMPANY SNAPSHOT
TABLE 02.VITA34 INTERNATIONAL: OPERATING SEGMENTS
TABLE 03.VIACORD: PRODUCT PORTFOLIO
TABLE 04.VITA34 INTERNATIONAL: COMPANY SNAPSHOT
TABLE 05.VITA34 INTERNATIONAL: OPERATING SEGMENTS
TABLE 06.VITA34 INTERNATIONAL: PRODUCT PORTFOLIO